Orthopedics Today reports that osteochondral autologous transplantation may be an effective treatment option for adolescent athletes with capitellar osteochondritis dissecans, according to results presented at the American Academy of Orthopaedic Surgeons Annual Meeting.

“This study has identified synovial inflammation as a significant component of the disease process,” Jose M. Gutierrez-Naranjo, MD, research fellow at HSS, said. “We found [osteochondral autologous transplantation surgery (OATS)] to effectively restore the osteochondral architecture, leading to long-term pain relief and preserved function in adolescent athletes.”

Dr. Gutierrez-Naranjo, Robert N. Hotchkiss, MD, hand and upper extremity surgeon at HSS, and colleagues retrospectively reviewed data from 17 adolescent athletes (mean age, 14 years; 15 men, two women) with capitellar osteochondritis dissecans who underwent osteochondral autologous transplantation surgery between 2009 and 2023.

Read the full article at healio.com.